Emma Johnson

681 total citations
11 papers, 234 citations indexed

About

Emma Johnson is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emma Johnson has authored 11 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emma Johnson's work include Cancer-related Molecular Pathways (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Emma Johnson is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Emma Johnson collaborates with scholars based in United Kingdom, United States and Germany. Emma Johnson's co-authors include Joanne Edwards, Andrew H. Sims, Nicola Ferrari, Stephen W. G. Tait, Kevin M. Ryan, Sandeep Dhayade, Karen Blyth, Susan Mason, Kirsteen J. Campbell and Gabriela Kalna and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Emma Johnson

9 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Johnson United Kingdom 4 152 92 37 34 18 11 234
Tuoyu Cao China 6 210 1.4× 92 1.0× 60 1.6× 54 1.6× 12 0.7× 7 278
Yuanming He China 9 246 1.6× 89 1.0× 41 1.1× 27 0.8× 25 1.4× 16 290
Paola Francica Switzerland 10 158 1.0× 124 1.3× 47 1.3× 57 1.7× 11 0.6× 14 249
Deniz Demircioğlu United States 6 133 0.9× 40 0.4× 56 1.5× 32 0.9× 16 0.9× 12 204
Tonći Šuštić Netherlands 7 192 1.3× 72 0.8× 53 1.4× 54 1.6× 12 0.7× 9 255
Frances M. Forrester United States 3 258 1.7× 113 1.2× 48 1.3× 23 0.7× 29 1.6× 4 304
Li-Ya Chiu Germany 8 218 1.4× 84 0.9× 48 1.3× 13 0.4× 11 0.6× 9 267
Louis Masclef Canada 5 138 0.9× 50 0.5× 33 0.9× 37 1.1× 11 0.6× 9 194
Zhong-Zhe Lin Taiwan 8 136 0.9× 102 1.1× 37 1.0× 37 1.1× 18 1.0× 9 232
Matthew D. Witkin United States 6 286 1.9× 81 0.9× 43 1.2× 20 0.6× 13 0.7× 8 365

Countries citing papers authored by Emma Johnson

Since Specialization
Citations

This map shows the geographic impact of Emma Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Johnson more than expected).

Fields of papers citing papers by Emma Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Johnson. The network helps show where Emma Johnson may publish in the future.

Co-authorship network of co-authors of Emma Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Johnson. A scholar is included among the top collaborators of Emma Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Johnson. Emma Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Perez, Kimberly, Matthew H. Kulke, Hui Zheng, et al.. (2025). A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors. The Oncologist. 30(1).
2.
Johnson, Emma, et al.. (2024). More Than Deoxygenation: Linking Iodate Reduction to Nitrogen, Iron, and Sulfur Chemistry in Reducing Regimes. Journal of Geophysical Research Oceans. 129(11). 2 indexed citations
3.
Malviya, Gaurav, Tamsin R.M. Lannagan, Emma Johnson, et al.. (2024). Noninvasive Stratification of Colon Cancer by Multiplex PET Imaging. Clinical Cancer Research. 30(8). 1518–1529. 2 indexed citations
4.
Christenson, Eric S., Jeremiah A. Wala, Rose Parkinson, et al.. (2024). Abstract CT007: Phase 1/2 trial of copanlisib in combination with nivolumab for microsatellite stable (MSS) colorectal cancer (CRC). Cancer Research. 84(7_Supplement). CT007–CT007. 2 indexed citations
5.
Malviya, Gaurav, Emma Johnson, Dmitry Soloviev, et al.. (2023). Positron emission tomography imaging of the sodium iodide symporter senses real-time energy stress in vivo. SHILAP Revista de lepidopterología. 11(1). 14–14.
6.
Gyurászová, Katarína, Claire Rooney, Ximena L. Raffo Iraolagoitia, et al.. (2023). Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma. SHILAP Revista de lepidopterología. 5. 1200650–1200650. 3 indexed citations
7.
Malviya, Gaurav, Rachana Patel, Mark J. Salji, et al.. (2020). 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy. EJNMMI Research. 10(1). 143–143. 17 indexed citations
8.
Menon, Malini, Richard Elliott, Rumana Rafiq, et al.. (2019). A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors. Scientific Reports. 9(1). 201–201. 39 indexed citations
9.
Campbell, Kirsteen J., Sandeep Dhayade, Nicola Ferrari, et al.. (2018). MCL-1 is a prognostic indicator and drug target in breast cancer. Cell Death and Disease. 9(2). 19–19. 144 indexed citations
10.
Edwards, Joanne, et al.. (2017). Investigating RUNX1 and RUNX2 in prostate cancer.. Journal of Clinical Oncology. 35(6_suppl). 232–232. 1 indexed citations
11.
Bate, Jessica, et al.. (2013). Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients (NICE Clinical Guideline CG151). Archives of Disease in Childhood Education & Practice. 98(2). 73–75. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tuoyu Cao Breakdown of academic impact, for papers by Yuanming He Breakdown of academic impact, for papers by Paola Francica Breakdown of academic impact, for papers by Deniz Demircioğlu Breakdown of academic impact, for papers by Tonći Šuštić Breakdown of academic impact, for papers by Frances M. Forrester Breakdown of academic impact, for papers by Li-Ya Chiu Breakdown of academic impact, for papers by Louis Masclef Breakdown of academic impact, for papers by Zhong-Zhe Lin Breakdown of academic impact, for papers by Matthew D. Witkin
Rankless by CCL
2026